Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: A Bayesian meta-analytic perspective

Critical Care

Volumn 14, Issue 4, 2010, Pages

  Moran, John L ^a   Graham, Petra L ^b   Rockliff, Sue ^a   Bersten, Andrew D ^c  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

^b MACQUARIE UNIVERSITY   (Australia)

^c FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE; CORTICOSTEROID; CORTICOTROPIN; DEXAMETHASONE; ETOMIDATE; HYDROCORTISONE; METHYLPREDNISOLONE; PLACEBO; PREDNISOLONE; STEROID;

ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG MEGADOSE; GASTROINTESTINAL HEMORRHAGE; HUMAN; HYPERGLYCEMIA; LOW DRUG DOSE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SECONDARY INFECTION; SEPSIS; SEPTIC SHOCK; TREATMENT OUTCOME; BAYES THEOREM; META ANALYSIS; REVIEW;

ADRENAL CORTEX HORMONES; BAYES THEOREM; HUMANS; SEPSIS; SHOCK, SEPTIC; TREATMENT OUTCOME;

EID: 77954409849     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc9182     Document Type: Article

References (89)

1. Weitzman S, Berger S. Clinical trial design in studies of corticosteroids for bacterial infections. Ann Intern Med 1974, 81:36-42.
2. Keh D, Weber-Carstens S, Ahlers O. Adjunctive therapies in severe sepsis and septic shock: Current place of steroids. Current Infectious Disease Reports 2008, 10:354-361. 10.1007/s11908-008-0058-z, 18687198.
3. Mesotten D, Vanhorebeek I, Van den Berghe G. The altered adrenal axis and treatment with glucocorticoids during critical illness. Nat Clin Pract Endocrinol Metab 2008, 4:496-505. 10.1038/ncpendmet0921, 18695699.
4. Cronin L, Cook DJ, Carlet J, Heyland DK, King D, Lansang MA, Fisher CJ. Corticosteroid treatment for sepsis: A critical appraisal and meta-analysis of the literature. Crit Care Med 1995, 23:1430-1439. 10.1097/00003246-199508000-00019, 7634816.
5. Lefering RM, Neugebauer EAMP. Steroid controversy in sepsis and septic shock: A meta-analysis. Crit Care Med 1995, 23:1294-1303. 10.1097/00003246-199507000-00021, 7600840.
6. Annane D, Bellissant E, Bollaert PE, Briegel J, Keh D, Kupfer Y. Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis. BMJ 2004, 329:480. 10.1136/bmj.38181.482222.55, 515196, 15289273.
7. Minneci PCM, Deans KJM, Banks SMP, Eichacker PQM, Natanson CM. Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose. Ann Intern Med 2004, 141:47-56.
8. Sprung CL, Annane D, Keh D, Moreno R, Singer M, Freivogel K, Weiss YG, Benbenishty J, Kalenka A, Forst H, Laterre PF, Reinhart K, Cuthbertson BH, Payen D, Briegel J, . CORTICUS Study Group Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008, 358:111-124. 10.1056/NEJMoa071366, 18184957, CORTICUS Study Group.
9. Annane D, Briegel J, Keh D, Moreno R, Singer M, Sprung CL, . Corticus Study Coordinators Clinical equipoise remains for issues of adrenocorticotropic hormone administration, cortisol testing, and therapeutic use of hydrocortisone. Crit Care Med 2003, 31:2250-2251. 10.1097/01.CCM.0000080485.75448.45, 12973194, Corticus Study Coordinators.
10. Minneci PC, Deans KJ, Banks SM, Eichacker PQ, Natanson C. Corticosteroids for Septic Shock. Ann Intern Med 2004, 141:742-743.
11. Annane D. Cortisol replacement for severe sepsis and septic shock: what should I do?. Critical Care 2002, 6:190-191. 10.1186/cc1486, 137442, 12133175.
12. Vincent JL. Steroids in sepsis: another swing of the pendulum in our clinical trials. Critical Care 2008, 12:141. 10.1186/cc6861, 2447597, 18466638.
13. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL, . International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327. 10.1097/01.CCM.0000298158.12101.41, 18158437, International Surviving Sepsis Campaign Guidelines Committee; American Association of Critical-Care Nurses; American College of Chest Physicians; American College of Emergency Physicians; Canadian Critical Care Society; European Society of Clinical Microbiology and Infectious Diseases; European Society of Intensive Care Medicine; European Respiratory Society; International Sepsis Forum; Japanese Association for Acute Medicine; Japanese Society of Intensive Care Medicine; Society of Critical Care Medicine; Society of Hospital Medicine; Surgical Infection Society; World Federation of Societies of Intensive and Critical Care Medicine.
14. Marik PE, Pastores SM, Annane D, Meduri GU, Sprung CL, Arlt W, Keh D, Briegel J, Beishuizen A, Dimopoulou I, Tsagarakis S, Singer M, Chrousos GP, Zaloga G, Bokhari F, Vogeser M, . American College of Critical Care Medicine Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: Consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008, 36:1937-1949. 10.1097/CCM.0b013e31817603ba, 18496365, American College of Critical Care Medicine.
15. Shojania KG, Sampson M, Ansari MT, Ji J, Doucette S, Moher D. How quickly do systematic reviews go out of date? A survival analysis. Ann Intern Med 2007, 147:224-233.
16. Finfer S. Corticosteroids in septic shock. N Engl J Med 2008, 358:188-190. 10.1056/NEJMe0708098, 18184965.
17. Sharp SJ, Thompson SG. Analysing the relationship between treatment effect and underlying risk in meta-analysis: comparison and development of approaches. Stat Med 2000, 19:3251-3274. 10.1002/1097-0258(20001215)19:23<3251::AID-SIM625>3.0.CO;2-2, 11113958.
18. Spiegelhalter DJ, Abrams KR, Myles JP. Bayesian approaches to clinical trials and health-care evaluation 2004, Chichester: John Wiley & Sons, Ltd.
19. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655. 10.1378/chest.101.6.1644, 1303622.
20. Peter JV, John P, Graham PL, Moran JL, George IA, Bersten A. Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis. BMJ 2008, 336:1006-1009. 10.1136/bmj.39537.939039.BE, 2364864, 18434379.
21. Warn DE, Thompson SG, Spiegelhalter DJ. Bayesian random effects meta-analysis of trials with binary outcomes: methods for the absolute risk difference and relative risk scales. Stat Med 2002, 21:1601-1623. 10.1002/sim.1189, 12111922.
22. Lunn DJ, Thomas A, Best N, Spiegelhalter D. WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility. Statistics and Computing 2000, 10:325-337.
23. Spruance SL, Reid JE, Grace M, Samore M. Hazard ratio in clinical trials. Antimicrob Agents Chemother 2004, 48:2787-2792. 10.1128/AAC.48.8.2787-2792.2004, 478551, 15273082.
24. Moran J, Solomon P, Warn D. Methodology in meta-analysis: a study from Critical Care meta-analytic practice. Health Services and Outcomes Research Methodology 2004, 5:207-226.
25. Sutton AJ, Cooper NJ, Abrams KR, Lambert PC, Jones DR. A Bayesian approach to evaluating net clinical benefit allowed for parameter uncertainty. J Clin Epidemiol 2005, 58:26-40. 10.1016/j.jclinepi.2004.03.015, 15649668.
26. Wijeysundera DN, Austin PC, Hux JE, Beattie WS, Laupacis A. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials. J Clin Epidemiol 2009, 62:13-21. 10.1016/j.jclinepi.2008.07.006, 18947971.
27. Woolcott JC, Richardson KJ, Wiens MO, Patel B, Marin J, Khan KM, Marra CA. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med 2009, 169:1952-1960. 10.1001/archinternmed.2009.357, 19933955.
28. Aitkin M, Francis B, Hinde J, Darnell R. Statistical modelling and inference. Statistical Modelling in R 2009, 28-96. Oxford OX2 6DP, UK: Oxford University Press.
29. Marik PE. Critical illness-related corticosteroid insufficiency. Chest 2009, 135:181-193. 10.1378/chest.08-1149, 19136406.
30. Rucker G, Schwarzer G, Carpenter J, Schumacher M. Undue reliance on I^2 in assessing heterogeneity may mislead. BMC Med Res Methodol 2009, 8.
31. Schumer W. Steroids in the treatment of clinical septic shock. Ann Surg 1976, 184:333-341. 10.1097/00000658-197609000-00011, 1344393, 786190.
32. Cooperative Study Group The effectiveness of hydrocortisone in the management of severe infections. JAMA 1963, 183:462-465. Cooperative Study Group.
33. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol 2008, 61:991-996. 10.1016/j.jclinepi.2007.11.010, 18538991.
34. Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Stat Med 2006, 25:3443-3457. 10.1002/sim.2380, 16345038.
35. Schwarzer G. meta: Meta-analysis. , http://cran.r-project.org/web/packages/meta/index.html
36. Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troché G, Chaumet-Riffaud P, Bellissant E. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002, 288:862-871. 10.1001/jama.288.7.862, 12186604.
37. Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 1998, 26:645-650. 10.1097/00003246-199804000-00010, 9559600.
38. Bone RC, Fisher CJ, Clemmer TP, Slotman GJ, Metz CA, Balk RA. A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987, 317:653-658. 10.1056/NEJM198709103171101, 3306374.
39. Briegel J, Forst H, Haller M, Schelling G, Kilger E, Kuprat G, Hemmer B, Hummel T, Lenhart A, Heyduck M, Stoll C, Peter K. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study. Crit Care Med 1999, 27:723-732. 10.1097/00003246-199904000-00025, 10321661.
40. Chawla K, Kupfer Y, Tessler S. Prognostic value of cortisol response in septic shock. JAMA 2000, 284:309.
41. Klastersky J, Cappel R, Debusscher L. Effectiveness of betamethasone in management of severe infections. A double-blind study. N Engl J Med 1971, 284:1248-1250. 10.1056/NEJM197106032842206, 4929896.
42. Oppert M, Schindler R, Husung C, Offermann K, Graf KJ, Boenisch O, Barckow D, Frei U, Eckardt KU. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med 2005, 33:2457-2464. 10.1097/01.CCM.0000186370.78639.23, 16276166.
43. Sprung CL, Caralis PV, Marcial EH, Pierce M, Gelbard MA, Long WM, Duncan RC, Tendler MD, Karpf M. The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study. N Engl J Med 1984, 311:1137-1143. 10.1056/NEJM198411013111801, 6384785.
44. Tandan SM, Guleria R, Gupta N. Low dose steroids and adrenocortical insufficiency in septic shock: A double-blind randomised controlled trial from India. Am J Respir Crit Care Med 2005, 171:A43.
45. Yildiz O, Doganay M, Aygen B, Guven M, Kelestimur F, Tutuu A. Physiological-dose steroid therapy in sepsis. Critical Care (London, England) 2002, 6:251-259. 10.1186/cc1498, 125315, 12133187.
46. Luce JM, Montgomery AB, Marks JD, Turner J, Metz CA, Murray JF. Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock. Am Rev Respir Dis 1988, 138:62-68.
47. Chawla K, Kupfer Y, Goldman I, Tessler S. Hydrocortisone reverses refractory septic shock. Crit Care Med 1999, 27:33A.
48. Annane D, Bellissant E, Bollaert PE, Briegel J, Confalonieri M, De Gaudio R, Keh D, Kupfer Y, Oppert M, Meduri GU. Corticosteroids in the treatment of severe sepsis and septic shock in adults: a systematic review. JAMA 2009, 301:2362-2375. 10.1001/jama.2009.815, 19509383.
49. Sprung CL, Annane D. Corticosteroids in septic shock. Controversies in Intensive Care Medicine 2008, 205-210. Berlin: Medizinisch Wissenschaftliche Verlagsgesellschaft, Kuhlen R, Moreno R, Ranieri M, Rhodes A.
50. Schaaf MJM, Cidlowski JA. Molecular mechanisms of glucocorticoid action and resistance. J Steroid Biochem Mol Biol 2002, 83:37-48. 10.1016/S0960-0760(02)00263-7, 12650700.
51. Cooper MS, Stewart PM. Adrenal Insufficiency in Critical Illness. J Intensive Care Med 2007, 22:348-362. 10.1177/0885066607307832, 18048877.
52. Dickstein G. On the term "relative adrenal insufficiency"--or what do we really measure with adrenal stimulation tests?. J Clin Endocrinol Metab 2005, 90:4973-4974. 10.1210/jc.2005-1196, 16087959.
53. de Jong MFC, Beishuizen A, Groeneveld AB. Defining relative adrenal insufficiency in the critically ill: The ACTH test revisited. Yearbook of Intensive Care and Emergency Medicine 2006, 539-551. Berlin: Springer-Verlag, Vincent JL.
54. Pintilie M. Competing risks: A practical perspective 2006, Chichester, UK: John Wiley & Sons Ltd.
55. Southern DA, Faris PD, Brant R, Galbraith PD, Norris CM, Knudtson ML, Ghali WA, . APPROACH Investigators Kaplan-Meier methods yielded misleading results in competing risk scenarios. J Clin Epidemiol 2006, 59:1110-1114. 10.1016/j.jclinepi.2006.07.002, 16980152, APPROACH Investigators.
56. Williamson PR, Kolamunnage-Dona R, Smith CT. The influence of competing risks setting on the choice of hypothesis test for treatment effect. Biostat 2007, 8:689-694.
57. Rhen T, Cidlowski JA. Antiinflammatory action of glucocorticoids -- new mechanisms for old drugs. N Engl J Med 2005, 353:1711-1723. 10.1056/NEJMra050541, 16236742.
58. Yang S, Zhang L. Glucocorticoids and vascular reactivity. Current Vascular Pharmacology 2004, 2:1-12. 10.2174/1570161043476483, 15320828.
59. Russell JA, Walley KR, Gordon AC, Cooper DJ, Hébert PC, Singer J, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, . Dieter Ayers for the Vasopressin and Septic Shock Trial Investigators Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock. Crit Care Med 2009, 37:811-818. 10.1097/CCM.0b013e3181961ace, 19237882, Dieter Ayers for the Vasopressin and Septic Shock Trial Investigators.
60. Keh D, Boehnke T, Weber-Cartens S, Schulz C, Ahlers O, Bercker S, et al. Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 2003, 167:512-520. 10.1164/rccm.200205-446OC, 12426230.
61. de Kruif MD, Lemaire LC, Giebelen IA, van Zoelen MA, Pater JM, van den Pangaart PS, Groot AP, de Vos AF, Elliott PJ, Meijers JC, Levi M, van der Poll T. Prednisolone dose-dependently influences inflammation and coagulation during human endotoxemia. J Immunol 2007, 178:1845-1851.
62. Arafah BM. Hypothalamic pituitary adrenal function during critical illness: limitations of current assessment methods. J Clin Endocrinol Metab 2006, 91:3725-3745. 10.1210/jc.2006-0674, 16882746.
63. Minneci P, Deans K, Natanson C, Eichacker PQ. Increasing the efficacy of anti-inflammatory agents used in the treatment of sepsis. European Journal of Clinical Microbiology & Infectious Diseases 2003, 22:1-9.
64. Seam N. Corticosteroids for septic shock: correspondence. N Engl J Med 2008, 358:2068-2069. 10.1056/NEJMc080246, 18467974.
65. Williamson PR, Gamble C, Altman DG, Hutton JL. Outcome selection bias in meta-analysis. Stat Methods Med Res 2005, 14:515-524. 10.1191/0962280205sm415oa, 16248351.
66. Annane D. Improving clinical trials in the critically ill: unique challenge--sepsis. Crit Care Med 2009, 37:S117-S128. 10.1097/CCM.0b013e318192078b, 19104211.
67. Bellomo RMFF, Warrillow SJM, Reade MCM. Why we should be wary of single-center trials. Crit Care Med 2009, 37:3114-3119. 10.1097/CCM.0b013e3181bc7bd5, 19789447.
68. Borm GF, Lemmers O, Fransen J, Donders R. The evidence provided by a single trial is less reliable than its statistical analysis suggests. J Clin Epidemiol 2009, 62(62(7)):711-715. e1, 10.1016/j.jclinepi.2008.09.013, 19171462.
69. Higgins JPT, Thornton A, Spiegelhalter DJ. A re-evaluation of random-effects meta-analysis. J R Stat Soc Ser A Stat Soc 2009, 172:137-159. 10.1111/j.1467-985X.2008.00552.x, 2667312, 19381330.
70. Sutton AJ, Cooper NJ, Jones DR, Lambert PC, Thompson JR, Abrams KR. Evidence-based sample size calculations based upon updated meta-analysis. Stat Med 2007, 26:2479-2500. 10.1002/sim.2704, 16981184.
71. Shrier I, Platt RW, Steele RJ. Mega-trials vs. meta-analysis: Precision vs. heterogeneity?. Contemporary Clinical Trials 2007, 28:324-328. 10.1016/j.cct.2006.11.007, 17188025.
72. Terrin N, Schmid CH, Lau J. In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias. J Clin Epidemiol 2005, 58:894-901. 10.1016/j.jclinepi.2005.01.006, 16085192.
73. Minneci PC, Deans KJ, Eichacker PQ, Natanson C. The effects of steroids during sepsis depend on dose and severity of illness: an updated meta-analysis. Clinical Microbiology and Infection 2009, 15:308-318. 10.1111/j.1469-0691.2009.02752.x, 19416302.
74. Jaeschke R, Angus DC. Living with uncertainty in the intensive care unit: should patients with sepsis be treated with steroids?. JAMA 2009, 301:2388-2390. 10.1001/jama.2009.829, 19509389.
75. Moran JL, Bersten AD, Solomon PJ. Meta-analysis of controlled trials of ventilator therapy in acute lung injury and acute respiratory distress syndrome: an alternative perspective. Intensive Care Med 2005, 31:227-235. 10.1007/s00134-004-2506-z, 15678318.
76. Borenstein M, Hedges LV, Higgins JP, Rothstein HR. Introduction to Meta-analysis 2009, West Sussex, UK: John Wiley & Sons, Ltd.
77. Finfer S. Corticosteroids in septic shock. N Engl J Med 2008, 358:188-190. 10.1056/NEJMe0708098, 18184965.
78. Wagner HN, Bennett IL, Lasagna L, Cluff LE, Rosenthal MB, Mirick GS. The effect of hydrocortisone upon the course of pneumococcal pneumonia treated with penicillin. Bull Johns Hopkins Hosp 1955, 98:197-215.
79. Thompson WL, Gurley HT, Lutz BA, Jackson BL, Kyols LK, Morris IA. Inefficacy of glucocorticoids in shock (double-blinded study). Clin Res 1976, 24:258A.
80. Lucas CE, Ledgerwood AM. The cardiopulmonary response to massive doses of steroids in patients with septic shock. Arch Surg 1984, 119:537-541.
81. The Veterans Administration Systemic Sepsis Cooperative Study Group Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. The Veterans Administration Systemic Sepsis Cooperative Study Group. N Engl J Med 1987, 317:659-665. 10.1056/NEJM198709103171102, 2888017, The Veterans Administration Systemic Sepsis Cooperative Study Group.
82. Schattner A, el-Hador I, Hahn T, Landau Z. Triple anti-TNF-alpha therapy in early sepsis: a preliminary report. J Int Med Res 1997, 25:112-116.
83. Confalonieri M, Urbino R, Potena A, Piattella M, Parigi P, Puccio G, Della Porta R, Giorgio C, Blasi F, Umberger R, Meduri GU. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study. Am J Respir Crit Care Med 2005, 171:242-248. 10.1164/rccm.200406-808OC, 15557131.
84. Rinaldi S, Adembri C, Grechi S, De Gaudio AR. Low-dose hydrocortisone during severe sepsis: effects on microalbuminuria. Crit Care Med 2006, 34:2334-2339. 10.1097/01.CCM.0000233872.04706.BB, 16850006.
85. Huh JW, Lim CM, Koh Y, Hong SB. Effect of low doses of hydrocortisone in patient with septic shock and relative adrenal insufficiency: 3 days versus 7 days treatment. Crit Care Med 2006, 34:A101.
86. Loisa P, Parviainen I, Tenhunen J, Hovilehto S, Ruokonen E. Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: a prospective randomized trial. Crit Care 2007, 11:R21. 10.1186/cc5696, 2151907, 17306016.
87. Nawab Q, Golden E, Confalonieri M, Umberger R, Meduri GU. Glucocorticoid (GC) Treatment in Severe Community-Acquired Pneumonia (CAP): Comparison of Hydrocortisone [HC] vs. Methylprednisolone [MP]. American Thoracic Society: International Conference 2007, A594.
88. Cicarelli DD, Vieira JE, Bensenor FE. Early dexamethasone treatment for septic shock patients: A prospective randomized clinical trial. Sao Paulo Medical Journal 2007, 125:237-241. 10.1590/S1516-31802007000400009, 17992396.
89. Kurugundla N, Irugulapati L, Kilari D, Amchentsev A, Devakonda A, George L, Raoof S. Effect of steroids in septic shock patients without relative adrenal insufficiency. American Thoracic Society: International Conference 2008, A116.